Search research articles
Contact Us
Filters
Showing results (171-180 of 180) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 180 results.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 9, 2022
NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022
Margaret von Mehren, John M Kane, Richard F Riedel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 13, 2022
Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Margaret von Mehren, John M Kane, Mark Agulnik, et al.
Cancer
|
October 28, 2022
Complete tumor necrosis after neoadjuvant chemotherapy defines good responders in patients with Ewing sarcoma
Santiago A Lozano-Calderón, Jose Ignacio Albergo, Olivier Q Groot, et al.
The Lancet. Oncology
|
July 24, 2020
Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial
Aaron R Weiss, Yen-Lin Chen, Thomas J Scharschmidt, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 11, 2026
NCCN Guidelines® Insights: Soft Tissue Sarcoma, Version 1.2025
Margaret von Mehren, John M Kane, Samantha A Armstrong, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 25, 2009
The role of the CD58 locus in multiple sclerosis
Philip L De Jager, Clare Baecher-Allan, Lisa M Maier, et al.
The Oncologist
|
August 13, 2022
Supporting Patients with Cancer after Dobbs v. Jackson Women's Health Organization
Andrew G Shuman, Matti S Aapro, Benjamin Anderson, et al.
Lancet (London, England)
|
March 30, 2024
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial
Sandra P D'Angelo, Dejka M Araujo, Albiruni R Abdul Razak, et al.
Nature Communications
|
June 15, 2022
Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma
Mrinal M Gounder, Narasimhan P Agaram, Sally E Trabucco, et al.
Nature Medicine
|
January 26, 2021
Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma
Livnat Jerby-Arnon, Cyril Neftel, Marni E Shore, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 180) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 180 results.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 9, 2022
NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022
Margaret von Mehren, John M Kane, Richard F Riedel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 13, 2022
Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Margaret von Mehren, John M Kane, Mark Agulnik, et al.
Cancer
|
October 28, 2022
Complete tumor necrosis after neoadjuvant chemotherapy defines good responders in patients with Ewing sarcoma
Santiago A Lozano-Calderón, Jose Ignacio Albergo, Olivier Q Groot, et al.
The Lancet. Oncology
|
July 24, 2020
Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial
Aaron R Weiss, Yen-Lin Chen, Thomas J Scharschmidt, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 11, 2026
NCCN Guidelines® Insights: Soft Tissue Sarcoma, Version 1.2025
Margaret von Mehren, John M Kane, Samantha A Armstrong, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 25, 2009
The role of the CD58 locus in multiple sclerosis
Philip L De Jager, Clare Baecher-Allan, Lisa M Maier, et al.
The Oncologist
|
August 13, 2022
Supporting Patients with Cancer after Dobbs v. Jackson Women's Health Organization
Andrew G Shuman, Matti S Aapro, Benjamin Anderson, et al.
Lancet (London, England)
|
March 30, 2024
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial
Sandra P D'Angelo, Dejka M Araujo, Albiruni R Abdul Razak, et al.
Nature Communications
|
June 15, 2022
Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma
Mrinal M Gounder, Narasimhan P Agaram, Sally E Trabucco, et al.
Nature Medicine
|
January 26, 2021
Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma
Livnat Jerby-Arnon, Cyril Neftel, Marni E Shore, et al.
Page
of 18